Ayman Al-Hendy | |
---|---|
Born | Ayman Al-Hendy 24 January 1964
Benha, Egypt |
Nationality | Egypt, Canada, United States |
Alma mater | Zagazig University, University of Turku, McMaster University, McGill University, University of Saskatchewan |
Scientific career | |
Institutions | University of Chicago, University of Illinois, Augusta University, Vanderbilt University, Meharry Medical College, University of Texas Medical Branch |
Ayman Al-Hendy, (born January 24, 1964) is a professor and director of translational research from Department of Obstetrics and Gynecology, University of Chicago. His branch of medical/surgical knowledge is obstetrics and gynecology, particularly in the spheres of “ gene/stem cell therapy”, “reproductive genetics”, and “ stem cell biology”. [1]
From 2014 to 2018 he served as a professor and Director for Division of Interdisciplinary Translational Research, Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta University (formerly Georgia Regents University), Augusta. Georgia [2] During 2007-2014, he was Scientific Director, Center for Women Health Research, Gynecologist/Obstetrician, professor and Vice Chair, Meharry Medical College, Nashville, Tennessee. [3] Al-Hendy published about 191 original peer-reviewed articles, [4] 24 books/chapters/reviews/case reports, and 239 abstracts presented at scientific conferences. [5]
Al-Hendy’s research has been continuously funded by the National institute of health (NIH, USA) since 2003. [6] He served as chair of the Integrative Clinical Endocrinology and Reproduction (ICER) 2012-2015. [7]
He received his M.D from Benha Faculty of Medicine Zagazig University, Benha, [8] Egypt in 1987, and soon after completion of his M.D, he started practicing as an intern at Benha University Hospital Benha, Egypt in 1988. He received his Ph.D. (DNA – laboratory) from Turku University, [9] Finland in 1992; and received postdoctoral research fellow in human genetics from McMaster University, Hamilton, Canada, in 1994 [10]
Rejuvenation of Premature Ovarian Failure with Stem Cells (ROSE) is Al-Hendy’s ongoing project. [11]
Ayman then corroborated studies to improve the health/medical care of women, and remove health discrepancy. He directed his attention to Uterine Fibroids Treatment and Research Center. [12]
{{
cite web}}
: CS1 maint: numeric names: authors list (
link)
{{
cite web}}
: CS1 maint: numeric names: authors list (
link)